Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (22) GO Terms (8) Nucleotides (474) Proteins (56) Interactants (372) Wiki
XB-GENEPAGE-974016

Papers associated with ube2i



???displayGene.coCitedPapers???
2 ???displayGene.morpholinoPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

A deficiency in SUMOylation activity disrupts multiple pathways leading to neural tube and heart defects in Xenopus embryos., Bertke MM, Dubiak KM, Cronin L, Zeng E, Huber PW., BMC Genomics. May 17, 2019; 20 (1): 386.              

Mitotic replisome disassembly depends on TRAIP ubiquitin ligase activity., Priego Moreno S, Jones RM, Poovathumkadavil D, Scaramuzza S, Gambus A., Life Sci Alliance. April 12, 2019; 2 (2):                       

Mitotic entry drives replisome disassembly at stalled replication forks., Hashimoto Y, Tanaka H., Biochem Biophys Res Commun. November 17, 2018; 506 (1): 108-113.      

SUMO co-expression modifies KV 11.1 channel activity., Steffensen AB, Andersen MN, Mutsaers N, Mujezinovic A, Schmitt N., Acta Physiol (Oxf). March 1, 2018; 222 (3):


Small ubiquitin-like modifier (SUMO)-mediated repression of the Xenopus Oocyte 5 S rRNA genes., Malik MQ, Bertke MM, Huber PW., J Biol Chem. December 19, 2014; 289 (51): 35468-81.                

SUMO modification of NZFP mediates transcriptional repression through TBP binding., Kim M, Chen Z, Shim MS, Lee MS, Kim JE, Kwon YE, Yoo TJ, Kim JY, Bang JY, Carlson BA, Seol JH, Hatfield DL, Lee BJ., Mol Cells. January 1, 2013; 35 (1): 70-8.

SUMO2/3 modification of cyclin E contributes to the control of replication origin firing., Bonne-Andrea C, Kahli M, Mechali F, Lemaitre JM, Bossis G, Coux O., Nat Commun. January 1, 2013; 4 1850.        

SUMOylated SoxE factors recruit Grg4 and function as transcriptional repressors in the neural crest., Lee PC, Taylor-Jaffe KM, Nordin KM, Prasad MS, Lander RM, LaBonne C., J Cell Biol. September 3, 2012; 198 (5): 799-813.              

Alternative TFAP2A isoforms have distinct activities in breast cancer., Berlato C, Chan KV, Price AM, Canosa M, Scibetta AG, Hurst HC., Breast Cancer Res. March 4, 2011; 13 (2): R23.              

PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity., Ryu H, Furuta M, Kirkpatrick D, Gygi SP, Azuma Y., J Cell Biol. November 15, 2010; 191 (4): 783-94.              

Sumoylation controls retinal progenitor proliferation by repressing cell cycle exit in Xenopus laevis., Terada K, Furukawa T., Dev Biol. November 1, 2010; 347 (1): 180-94.                                                  

SUMO modification regulates the transcriptional activity of MAML1., Lindberg MJ, Popko-Scibor AE, Hansson ML, Wallberg AE., FASEB J. July 1, 2010; 24 (7): 2396-404.

Ubiquitin/SUMO modification of PCNA promotes replication fork progression in Xenopus laevis egg extracts., Leach CA, Michael WM., J Cell Biol. December 19, 2005; 171 (6): 947-54.                

SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation., Taylor KM, Labonne C., Dev Cell. November 1, 2005; 9 (5): 593-603.                  

PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes., Azuma Y, Arnaoutov A, Anan T, Dasso M., EMBO J. June 15, 2005; 24 (12): 2172-82.

SUMO-2/3 regulates topoisomerase II in mitosis., Azuma Y, Arnaoutov A, Dasso M., J Cell Biol. November 10, 2003; 163 (3): 477-87.            

Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling., Lee PS, Chang C, Liu D, Derynck R., J Biol Chem. July 25, 2003; 278 (30): 27853-63.

Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex., Zhang H, Saitoh H, Matunis MJ., Mol Cell Biol. September 1, 2002; 22 (18): 6498-508.

Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358., Saitoh H, Pizzi MD, Wang J., J Biol Chem. February 15, 2002; 277 (7): 4755-63.

Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue., Lee GW, Melchior F, Matunis MJ, Mahajan R, Tian Q, Anderson P., J Biol Chem. March 13, 1998; 273 (11): 6503-7.

Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2., Saitoh H, Sparrow DB, Shiomi T, Pu RT, Nishimoto T, Mohun TJ, Dasso M., Curr Biol. January 15, 1998; 8 (2): 121-4.

Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins., Seufert W, Futcher B, Jentsch S., Nature. January 5, 1995; 373 (6509): 78-81.

???pagination.result.page??? 1